US equity
·Updated Oct 12, 21:38 UTCPRCT
PROCEPT BioRobotics Corporation
Health Care·Small cap·$1.1B
19.57
+6.4% today
No price history available for this name yet.
Returns & momentum
1D+6.4%
1W+9.8%
1M-4.0%
3M+1.4%
6M-16.6%
1Y-43.8%
YTD—
All-time—
Range & moving averages
Price19.57
52w high-48.6%
52w low+17.4%
All-time high—
All-time low—
% from ATH—
50-day MA—
vs 50-DMA—
200-day MA—
vs 200-DMA—
Liquidity & activity
Volume2M
Turnover$40M
Market cap$1.1B
RVOL1.55×
Risk & valuation
Real. vol 30d—
Real. vol 90d—
Max drawdown—
Beta · SPY—
P/E—
P/B—
ROE—
Div yield—
Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $308M | $224M | $136M | $75M | $34M | $8M |
| Cost of revenue | $112M | $87M | $65M | $38M | $19M | $9M |
| Gross profit | $196M | $137M | $71M | $37M | $16M | -$1M |
| Research & development | $71M | $62M | $48M | $29M | $19M | $16M |
| Selling, general & admin | $229M | $171M | $132M | $89M | $51M | $30M |
| Operating expenses | $300M | $234M | $180M | $118M | $70M | $47M |
| Operating income | -$104M | -$97M | -$109M | -$81M | -$54M | -$48M |
| Interest expense | — | — | $4M | $5M | $6M | $5M |
| Income tax | $190K | $368K | $80K | $0 | $0 | $0 |
| Net income | — | — | — | — | — | -$53M |
| EPS — basic | -$1.72 | -$1.75 | -$2.24 | -$1.96 | -$3.63 | -$14.47 |
| EPS — diluted | -$1.72 | -$1.75 | -$2.24 | -$1.96 | -$3.63 | -$14.47 |
| Shares — basic | 55.54M | 52.13M | 47.26M | 44.4M | 16.48M | 3.66M |
| Shares — diluted | 55.54M | 52.13M | 47.26M | 44.4M | 16.48M | 3.66M |
From SEC filings (public domain), since 2020. Values as reported (USD); per-share figures are per diluted/basic share. Point-in-time — each figure reflects the latest amount filed for that period. Descriptive context only, not advice.
Informational scan, not a buy/sell recommendation or financial advice in any jurisdiction.